Soluble RAGE (sRAGE) levels were markedly lower in both COPD groups compared to controls, with the highest levels noted in healthy individuals, implying a potential role in disease pathogenesis or severity (Table 1). This evidence concerns the gene AGER and chronic obstructive pulmonary disease.